Zokinvy
Product Images NDC 73079-050

12 FDA label images from Eiger Biopharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Zokinvy (NDC 73079-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eiger Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lonafarnib 01)

Chemical Structure (Lonafarnib 01)
Chemical structure diagram of the active ingredient in Zokinvy, showing a complex organic molecule with bromine, chlorine, and nitrogen atoms arranged in multiple rings and side chains.*
FDA Label Image

Chemical Structure (Lonafarnib 02)

Chemical Structure (Lonafarnib 02)
A Kaplan-Meier survival probability curve comparing Zokinvy treatment with untreated controls over a time span of up to 13 years. The graph plots survival probability on the vertical axis against time in years on the horizontal axis. Two curves are shown: one for Zokinvy (solid blue line) and one for untreated (dashed red line), each with censored data points indicated. The graph includes numbers at risk below the time axis for both groups.*
FDA Label Image

Figure-mixing (Lonafarnib 03)

Figure-mixing (Lonafarnib 03)
An instructional diagram showing four circular illustrations related to dosing Zokinvy. It includes a dosing cup with 5 mL and 10 mL markings, a small spoon positioned horizontally, a clear dosing cup viewed from the top filled to a level, and a small spoon viewed from an angle, suggesting measurement and administration tools for the medication.*
FDA Label Image

Figure A (Lonafarnib 04)

Figure A (Lonafarnib 04)
An instructional illustration labeled 'Figure A' showing a medicine cup marked at 5 mL and 10 mL, with arrows indicating to fill to either of these levels. It also depicts one or two teaspoons of applesauce as an alternative method of administration, associated with the drug Zokinvy by Eiger BioPharmaceuticals, Inc.*
FDA Label Image

Figure B (Lonafarnib 05)

Figure B (Lonafarnib 05)
An instructional illustration labeled Figure B showing options for administering a liquid medication. It depicts pouring 5 mL or 10 mL of Ora-Blend SF, Ora-Plus, or orange juice into a cup, or alternatively, taking 1 or 2 teaspoonfuls of applesauce from a spoon.*
FDA Label Image

Figure C,d (Lonafarnib 06)

Figure C,d (Lonafarnib 06)
Illustrations labeled Figure C and Figure D show hands manipulating a small round object above a cup. Figure C depicts pinching the object and moving it side to side, while Figure D shows crumbling the object with fingers and dispensing it into the cup. These appear to be instructive steps for preparing Zokinvy.*
FDA Label Image

Figure E (Lonafarnib 07)

Figure E (Lonafarnib 07)
Figure E is an instructional illustration showing a glass with liquid and a spoon stirring it. It includes the text listing mixing options: Ora-Blend SF, Ora-Plus, orange juice, or applesauce, suggesting suitable substances for mixing a medication.*
FDA Label Image

Figure Logo (Lonafarnib 08)

Figure Logo (Lonafarnib 08)
An instructional diagram showing a clock face with an arrow and the text 'WITHIN 10 Minutes' inside the circle, indicating a time period or timing instruction.*
FDA Label Image

50 mg 30-count Bottle Label (Lonafarnib 09)

50 mg 30-count Bottle Label (Lonafarnib 09)
Zokinvy (lonafarnib) capsules 50 mg label with a 30-capsule package count. The label includes the NDC number 73079-050-30, active ingredient dosage, inactive ingredients, storage instructions, and distributor information for Eiger BioPharmaceuticals, Inc.*
FDA Label Image

50 mg 30-count Bottle Carton Label (Lonafarnib 10)

50 mg 30-count Bottle Carton Label (Lonafarnib 10)
Packaging label for Zokinvy (lonafarnib) capsules 50 mg, presented in a carton for 30 capsules. The label includes dosing storage instructions, active and inactive ingredient details, and manufacturer information, distributed by Eiger BioPharmaceuticals, Inc. The capsules are described as opaque yellow and imprinted with LNF 50.*
FDA Label Image

75 mg 30-count Bottle Label (Lonafarnib 11)

75 mg 30-count Bottle Label (Lonafarnib 11)
Label for Zokinvy (lonafarnib) capsules 75 mg by Eiger BioPharmaceuticals, Inc. The label indicates a package containing 30 capsules, with dosage and storage instructions. The active ingredient is lonafarnib 75 mg per capsule. Inactive ingredients and distributor information are also shown.*
FDA Label Image

75 mg 30-count Bottle Carton Label (Lonafarnib 12)

75 mg 30-count Bottle Carton Label (Lonafarnib 12)
Packaging label for Zokinvy (lonafarnib) capsules 75 mg by Eiger BioPharmaceuticals, Inc. The label indicates a 30-capsule package. Capsules are described as opaque light orange, imprinted with LNF 75. The label also includes storage instructions, ingredients, barcode, lot number, expiration, and distributor contact details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.